SCHEMBL1840558

SCHEMBL1840558

COc1ccc(C2(C(C(=O)N(Cc3ccccc3)N=O)C3CCCCC3)Nc3cc(F)c(F)cc3N2)c(OC)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.35
NR1H4 Q96RI1 2/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
MMP1 P03956 1/20 0.32
MMP9 P14780 1/20 0.32
MMP13 P45452 1/20 0.32
ADAM17 P78536 1/20 0.32
TP53 P04637 2/20 0.32
MAPT P10636 1/20 0.32
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
CTSD P07339 1/20 0.31
ALDH1A1 P00352 1/20 0.30
LMNA P02545 1/20 0.30
YAP1 P46937 1/20 0.30
TEAD4 Q15561 1/20 0.30
EP300 Q09472 1/20 0.30
CREBBP Q92793 1/20 0.30
SLC6A9 P48067 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1841564 0.84 NR1H4 (0.40) L3MBTL1NR1H4KMT2AMMP1MAPT
SCHEMBL3657230 0.83 NR1H4 (0.41) NR1H4
SCHEMBL1839859 0.77 AGER (0.37) L3MBTL1MEN1KMT2ALMNA
SCHEMBL3801443 0.76 NR1H4 (0.56) NR1H4MEN1KMT2ATP53ALDH1A1
SCHEMBL3654638 0.76 NR1H4 (0.46) NR1H4MEN1KMT2ACTSD
SCHEMBL1843649 0.76 NR1H4 (0.36) NR1H4
SCHEMBL3657964 0.74 NR1H4 (0.44) NR1H4
SCHEMBL1839973 0.74 NR1H4 (0.38) NR1H4
SCHEMBL1840133 0.74 NR1H4 (0.36) NR1H4
SCHEMBL1842712 0.74 AGER (0.34) MEN1KMT2AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321282-A1 NEW BENZIMIDAZOLE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2011-05-18 EP disclosed
WO-2010028981-A1 NEW BENZIMIDAZOLE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2010-03-18 WO disclosed